Last reviewed · How we verify
NCT05216549: postcovidkids
Water and Land-based Exercise for Children With Post COVID-19 Condition
NA trial testing Water-based exercise in COVID-19 in 75 participants. Completed in 30 June 2022.
5 June 2022
Quick facts
| Lead sponsor | Józef Piłsudski University of Physical Education |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 January 2022 |
| Primary completion | 5 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Water-based exercise
- Land-based exercise
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Children, Only — all drugs for Children, Only →
- Lung Function Decreased — all drugs for Lung Function Decreased →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Józef Piłsudski University of Physical Education
Who can join
Adults 10 to 12, any sex, with COVID-19 or Children, Only. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The latest data indicate that post COVID-19 condition is frequent in children and adolescents, with the most common symptoms being fatigue, shortness of breath, exercise intolerance and weakness. Evidence that COVID-19 can have significant long-term effects on children's health highlights the need for measures to reduce the impact of the pandemic on children, ensuring that they receive appropriate treatments. Those experiencing post COVID-19 condition require more tailored exercise-related advice and improved support to be able to resume activities important to their individual well-being. To the best of our knowledge, no studies have yet addressed the issue of exercise programs for children with post COVID-19 condition. The aim of this study, therefore, is to evaluate the effectiveness of different interventions on pulmonary function, exercise capacity, fatigue and quality of life in children with post COVID-19 condition. This will be a randomized controlled study with pre and post intervention assessment. Children will be recruited from primary schools and primary health care units in Warsaw. Participants meeting the inclusion criteria will be randomized to one of 3 groups: water-based exercise, land-based exercise or control (no exercise). The water-based and land-based exercise groups will be held twice a week, 45 min per session for 8 weeks. Participants will be assessed at baseline and immediately post-intervention in terms of changes in pulmonary function, exercise capacity, fatigue and quality of life. Research outcomes will build the evidence-based practice for health professionals.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Water-Based and Land-Based Exercise for Children with Post-COVID-19 Condition (postCOVIDkids)-Protocol for a Randomized Controlled Trial.
Ogonowska-Slodownik A, Labecka MK, Kaczmarczyk K, McNamara RJ, et al · · 2022 · cited 9× · PMID 36361362 · DOI 10.3390/ijerph192114476 -
Effect of Water-Based vs. Land-Based Exercise Intervention (postCOVIDkids) on Exercise Capacity, Fatigue, and Quality of Life in Children with Post COVID-19 Condition: A Randomized Controlled Trial.
Ogonowska-Slodownik A, Labecka MK, Maciejewska-Skrendo A, McNamara RJ, et al · · 2023 · cited 3× · PMID 37834888 · DOI 10.3390/jcm12196244 -
Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial.
Ogonowska-Slodownik A, Labecka MK, Maciejewska-Skrendo A, Morgulec-Adamowicz N, et al · · 2025 · cited 1× · PMID 40551803 · DOI 10.1183/23120541.00838-2024 -
Effect of water-based vs. land-based exercise intervention (postCOVIDkids) on exercise capacity, fatigue and quality of life in children with post COVID-19 condition: a randomized controlled trial
Ogonowska-Slodownik A, Labecka M, Maciejewska-Skrendo A, McNamara R, et al · · 2023 · cited 1× · DOI 10.21203/rs.3.rs-2847841/v1
Verify or expand the search:
- PubMed search for NCT05216549
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Józef Piłsudski University of Physical Education trials
Trials by the same sponsor.
- NCT07061041 — Comparison of the Effects of Static Stretching and Full Range of Motion Strength Training on Posterior Band Flexibility · NA · recruiting
- NCT06960590 — Determining the Minimal Effective Dose of Static Stretching for Increasing Range of Motion in Adults · NA · active not recruiting
- NCT06821477 — Impact of Knee Extension Brace on Quadriceps EMG During ASLR · active not recruiting
- NCT06804564 — Cold Vs Warm Water Immersion for DOMS Recovery · NA · recruiting
- NCT06896773 — Effect of Training in Normobaric Hypoxia on Cardiac Markers · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05216549 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Józef Piłsudski University of Physical Education
- Last refreshed: 10 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05216549.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing